CARDIFF ONCOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
CARDIFF ONCOLOGY, INC. (CRDF) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 15.15 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 15.15M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 12.15M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 12.15M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 12.15M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2026-06-30 | 15.15M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 12.15M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 12.15M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 12.15M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 12.15M shares 10-Q · filed 2025-07-29 |
| 2025-03-31 | 8.15M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 8.15M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 8.15M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 8.15M shares 10-Q · filed 2024-08-08 |
| 2024-06-20 | 8.15M shares 10-K · filed 2026-02-24 |
| 2022-09-30 | 3.15M shares 10-Q · filed 2023-11-02 |
| 2022-06-30 | 3.15M shares 10-Q · filed 2023-08-09 |
| 2022-06-09 | 5.15M shares 10-Q · filed 2024-05-02 |
| 2022-03-31 | 3.15M shares 10-Q · filed 2023-05-04 |
| 2021-12-31 | 3.15M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 3.15M shares 10-Q · filed 2022-11-03 |
| 2021-06-30 | 3.15M shares 10-Q · filed 2024-05-02 |
| 2009-12-31 | 3.67M shares 10-K · filed 2014-03-17 |
| 2006-04-04 | 2.00M shares 10-K · filed 2014-03-17 |
| 2006-04-03 | 833.33K shares 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |